ePlaza Magazine
Submit news for free

Johnson & Johnson achieves Q3 profit, raises full year forecast

Johnson & Johnson has achieved a Q3 profit of $3.393 billion, with sales of $20.35 billion for the three months ending September 30th.

Topping the general consensus, the company has raised its full year outlook to an adjusted EPS of $8.13 to $8.18, with expected sales of $81.0 billion to $81.4 billion.

Alex Gorsky, CEO and Chairman said, “We are pleased with our strong third-quarter performance, which reflects continued above-market growth in our pharmaceutical business, accelerating sales momentum in our consumer business and consistent progress in our medical devices business.
“I’m confident that with our collaborative and inspired J&J colleagues around the world, unique broad-based business model and strategic investments in innovation, we are well positioned for success today and into the future.”

Worldwide consumer sales rose 1.8 percent year on year to $3.4 billion. Domestic sales increased 6.6 percent while international sales decreased 1.3 percent due to an operational increase of 3.7 percent and a negative currency impact of 5 percent.

The post Johnson & Johnson achieves Q3 profit, raises full year forecast appeared first on Global Cosmetics News.

Comments are closed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More